Aytu outlines $6M-$7M quarterly sales and marketing spend range as EXXUA scripts rise to over 920 in April
AYTU BioPharma, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $2.15
-8.4% in 3d after detection
Post-detection moves
1h
—
1d
-3.5%
3d
-8.4%
7d
-4.0%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS